|
Jun 30
|
AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals
|
|
Jun 30
|
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025
|
|
Jun 29
|
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery
|
|
Jun 28
|
AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer
|
|
Jun 27
|
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
|
|
Jun 27
|
3 UK Stocks That May Be Trading Below Their Estimated Value In June 2025
|
|
Jun 27
|
Why AstraZeneca risks Trump’s wrath with bet on China
|
|
Jun 26
|
Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect.
|
|
Jun 26
|
Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic?
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 26
|
UK's June 2025 Stock Picks Estimated Below Intrinsic Value
|
|
Jun 6
|
Why Is Techne (TECH) Down 3% Since Last Earnings Report?
|
|
Jun 6
|
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
|
|
Jun 6
|
Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
|
|
Jun 5
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 5
|
Global Markets Are On a Tear. These Stocks in Europe and Japan Are Still Bargains.
|
|
Jun 4
|
Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.
|
|
Jun 3
|
AstraZeneca (LSE:AZN) Reports Positive Trial Results For ENHERTU® In Breast Cancer Treatment
|
|
Jun 3
|
UK Stocks That Might Be Priced Below Estimated Value
|
|
Jun 2
|
Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors
|